Abstract:Abstract Background: Either sequential organ failure assessment (SOFA) score or chest CT severity score (CT-SS) is often used alone to evaluate the prognosis of patients with critical coronavirus disease 2019 (COVID-19), but each of them has intrinsic deficiency. Herein, we attempted to investigate the predictive value of the combination of SOFA and CT-SS for the prognosis of COVID-19. Materials and Methods: A single-center retrospective study was performed in the Second Affiliated Hospital of Zhejiang University School of Medicine from December 2022 to January 2023. Patients with critical COVID-19 pneumonia were divided into two groups of survival or non-survival of hospitalization. The data including clinical characteristics, CT-SS, SOFA score, laboratory results on admission day were collected and analyzed. In addition, the predictive value of SOFAscore, chest CT-SS, or their combination for in-hospital mortality of COVID-19 pneumonia were compared by receiver operating characteristic (ROC) curve. Results: A total of 424 patients with a mean age of 75.46 years and a major proportion of male (69.10%) were finally enrolled, and the total in-hospital mortality was 43.40% (184/424). In comparison with survival group, significant higher proportions of older age (>75 years), comorbidities including obesity, diabetes, and cerebrovascular disease, more needs of mechanical ventilation and continuous renal replacement therapy (CRRT) were observed in the non-survival group (all P﹤0.05). In addition, non-survival patients had a higher value of creatinine, procalcitonin, C-reactive protein, interleukin-6 , SOFA score , CT-SS (all P﹤0.05) on admission day. Multivariate logistic regression analysis further showed that older age, obesity, diabetes, SOFA score, CT-SS, mechanical ventilation, and lymphocytopenia (all P﹤0.05) were independently related with in-hospital mortality. Moreover, the area under the curve (AUC) of combination of SOFA score and chest CT-SS became significant higher than their respective alone (P＜0.01). Conclusion: A simple combination of SOFA scorewith chest CT-SS on admission elicits a better predictive value for in-hospital mortality of critical COVID-19 patients, which could also serve as a promising indicator for prognosis prediction of other severe lung diseases like severe pneumonia and acute lung injury.

Comparison of liver fibrosis scores and fatty liver on computed tomography as risk factors for severity of COVID-19

Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19

Prognostic value of SOFA combined with chest CT severity score in patients with critical COVID-19 pneumonia: a retrospective study

Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19

Risk of Severe Illness of COVID-19 Patients with NAFLD and Increased NAFLD Fibrosis Scores.

Abnormal liver function on admission predicts severe outcomes in COVID-19 patients: a multicenter study (Preprint)

Liver Injury in Patients with COVID-19: A Retrospective Study

TGF-β and CCL18 as Indicators for Predicting and Monitoring the Development of Pulmonary Fibrosis in Patients with COVID-19

The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?

An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19

The Association Between the Fibrosis-4 Index and COVID-19: A Systematic Review and Meta-Analysis.

Effect of Liver Injury on Prognosis and Treatment of Hospitalized Patients with COVID-19 Pneumonia

Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity

Comparison of Liver Fibrosis Scores for Predicting Mortality and Morbidity in Heart Failure with Preserved Ejection Fraction

Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic

Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study

The Indicative Role of Markers for Liver Injury on the Severity and Prognosis of Coronavirus Disease 2019 Patients

Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.

Prognostic Potential of Liver Enzymes in Patients With COVID-19 at the Leishenshan Hospital in Wuhan

Clinical Features of Patients With COVID-19 With Nonalcoholic Fatty Liver Disease

Liver dysfunction on admission worsens clinical manifestations and outcomes of coronavirus disease 2019